Income Taxes	9 Months Ended
Sep. 30, 2014
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The Company is subject to income tax in the United States as well as other tax jurisdictions in which it conducts business. Earnings from non-U.S. activities are subject to local country income tax. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are to be reinvested indefinitely. The Company recorded income tax expense of $0.2 million and $0.3 million for the three months ended September 30, 2014 and 2013, respectively and $0.7 million for the nine months ended September 30, 2013 and recorded income tax benefit of $0.2 million for the nine months ended September 30, 2014. These income tax expense (benefit) amounts were primarily attributable to foreign taxes. Factors that impact the income tax provision include, but are not limited to, stock-based compensation expense, permanent tax adjustments, foreign operations and a valuation allowance against the Company’s deferred tax assets.

Income Taxes

9 Months Ended

Sep. 30, 2014

12. Income Taxes

The Company is subject to income tax in the United States as well as other tax jurisdictions in which it conducts business. Earnings from non-U.S. activities are subject to local country income tax. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are to be reinvested indefinitely. The Company recorded income tax expense of $0.2 million and $0.3 million for the three months ended September 30, 2014 and 2013, respectively and $0.7 million for the nine months ended September 30, 2013 and recorded income tax benefit of $0.2 million for the nine months ended September 30, 2014. These income tax expense (benefit) amounts were primarily attributable to foreign taxes.

Factors that impact the income tax provision include, but are not limited to, stock-based compensation expense, permanent tax adjustments, foreign operations and a valuation allowance against the Company’s deferred tax assets.